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Abstract 
It was observed that pressure of host immune system leads to diversifying selection (which can 
be measured in terms of pN/pS ratio). In this research we checked whether Plasmodium 
falciparum proteins containing experimentally evident epitopes from the IEDB database are 
subject to diversifying selection. We also investigated which life stage of this parasite and which 
proteins are subject to the strongest immune pressure. To answer these questions we used 
information about experimentally evident epitopes from Plasmodium, that interact with human 
immune system and sequences of different isolates of P. falciparum. 
We confirmed the expectations that proteins containing IEDB epitopes are subject to stronger 
diversifying selection which is evidenced by higher pN/pS ratio. A stage characterized by the 
highest average pN/pS ratio is that of the sporozoite. The greatest fraction of putative antigens is 
also present at this stage. We also found that the sporozoite stage is particularly interesting for 
further analysis as it potentially contains the highest number of unidentified epitopes. 
1. Introduction 
Malaria is one of the most serious parasitic infections affecting humanity. It causes about one 
million deaths and over 200 million infections globally each year (WHO World Malaria Report, 
2010). There are four major species belonging to Plasmodium genus that were found to be 
responsible for causing malaria in humans: P. falciparum, P. vivax, P. malariae and P. ovale. 
Among them, P. falciparum causes the most severe and lethal form of this disease (Greenwood, 
2005). 
The life cycle of P. falciparum is complex since its nature requires expression of multiple 
specialized proteins necessary to survive in both invertebrate (mosquito) and vertebrate (human) 
host organisms as well as for the invasion of different types of cells (Florens et al., 2002). Due to 
the complexity of the life cycle, each life stage expresses a number of antigenic proteins that can 
induce an immune response and which presents a real challenge for vaccine design (Vaughan 
et al., 2009). 
Another aspect,  characteristic for Plasmodium parasites is their high genetic variability. The 
important factor that determines this variability is a number of single nucleotide polymorphisms 
(SNPs) (Ekland and Fidock, 2007; Jeffares et al., 2007; Volkman et al., 2007), or, more 
precisely, the ratio of non-synonymous to synonymous SNPs (pN/pS). Research has revealed 
that recombination rates are variable for P. falciparum strains and achieve the highest values for 
African strains (Mu et al., 2005). It was also observed that genes related to immunity are under 
stronger diversifying selection when compared to other genes as they have higher pN/pS ratio 
(Jeffares et al., 2007; Neafsey  et al., 2008). Identification and characterization of such genes 
may be crucial for better understanding of the disease, its different clinical manifestations and 
potential resistance to vaccination (Richie and Saul, 2002).  
The publication of the Plasmodium falciparum genome and the development of novel genetic 
and bioinformatics tools offer new possibilities for detailed analysis. Hitherto the sequences of 
approximately 5300 proteins were annotated for Plasmodium falciparum  genome (Gardner  et 
al., 2002). Among them, there were identified about 4500 unique epitopes (present in about 1500 
proteins), which are short protein motifs recognized by the host immune system (Vaughan et al., 
2009). All useful data about evident epitopes from Plasmodium and many other species are 
collected by IEDB – Immune Epitope Database and Analysis Resource 
(www.immuneepitope.org, Vita, 2009). In another useful resource known as PlasmoDB 
(www.plasmodb.org, Aurrecoechea et al., 2009) those epitopes were mapped in relationship to 
Plasmodium proteins. Such proteins are regarded as antigens as they can elicit response of the 
host immune system. 
The aim of this research was to use data collected in PlasmoDB and IEDB to investigate whether 
these antigens are subject to diversifying selection.  We have also employed an analysis of 
epitopes and SNPs to compare the immunogenicity across developmental stages and different 
protein classes from Plasmodium.  
Recent study of Tetteth et. al (2009), based on deep resequencing, has shown that set of best 
known antigens are subject of balancing and diversifying selection. That was demonstrated by 
using different population genetic tests (McDonald-Kreitman test, HKA test, and Tajima’s D). 
These results shows that comparison between currently existing diversity and genome of 
P. reichenovi may reveal immune pressure acting on pathogen after the speciation.  
However, these tests require very good quality sequences obtained from many isolates. 
Unfortunately majority of accessible genomes are only rough draft and often available sequences 
do not cover the full gene length. Therefore it is hard to use this type of statistics for global 
genome scan.  This is why we decided to analyze the ratio of non-synonymous versus 
synonymous SNPs and check if this ratio is elevated in antigens. Another advantage of this 
approach is the fact that this it tests selection occurring recently during evolution of new 
infection strains, which are much more closely related than different species (P. reichenowi and 
P. falciparum).  Therefore one could find it useful in epidemiological studies. Simplicity of this 
approach cause its robustness to unusual situations which may lead to the false signals in other 
tests (for example stronger pressure on antigen and higher speed of protein evolution during 
speciation of Plasmodium falciparum versus Plasmodium reichenowi than immune pressure 
observed now).   
2. Methods 
In the following research we aimed to investigate whether the immunogenicity of different 
malaria protein classes is correlated with differences in the frequency of molecular evolutionary 
changes observed in the available data. The whole analysis was divided into two parts – the first 
was focused on the general analysis of the proteome and the second on the investigation of 
evolutionary changes. 
Plasmodium falciparum has a complex life cycle and each of its developmental stages is 
characterized by a unique protein expression profile. In the first part of the research we took into 
consideration individual merozoite, trophozoite, gametocyte, and sporozoite proteomes. We used 
the set of 2384 proteins described in PlasmoDB 8.1 which expression in investigated stages was 
confirmed by mass spectroscopy (Florens et al. 2002).  
All the data used in the second part of the research were also obtained from the PlasmoDB 
project website. For this analysis the ratio of the number of non-synonymous single nucleotide 
polymorphisms (pN) to those of synonymous ones (pS) was necessary (See the table in 
supplementary materials). Several different methods for investigation of natural selection have 
been developed. In this analysis we decided to use the pN/pS ratio for this purpose.  For 
comparison we conducted also Ka/Ks ratio test (see supplementary materials). This method 
considers the correction for the number of synonymous and non-synonymous sites within the 
gene structure (Nei and Gojobori, 1986). We did no decide to use it as the main method in this 
research since such a correction is justified only in analysis of sequences obtained from different 
species since in case of different genes the probability of occurrence of synonymous mutation 
due to random chance is different. This is caused by the gene structure and codons composition. 
However, in the analysis of polymorphism there is another fundamental problem caused by the 
fact that often number of synonymous SNPs is equal to 0. We approximated such cases by 
number 1. Although such a correction is far from being perfect, it is hard to add justified 
correction for gene structure in such cases.  
McDonald-Kreitman test (McDonald and Kreitman, 1991) and similar methods such as HKA 
test (Hudson et al., 1987) shows if non-synonymous protein mutations present as polymorphisms 
tend to be fixed in the longer period of time. When MK test indicates that such polymorphisms 
tend to be removed by selection it may indicate the action of diversifying selection or 
accumulation of deleterious polymorphisms, which are gradually removed by purifying 
selection. In case of Plasmodium it has been demonstrated by MK and HKA tests that well 
known antigens are subject of diversifying/purifying selection (Polley and Conway, 2001, Baum 
et al., 2002). In contrast it is expected that in case of good vaccine candidates polymorphisms are 
usually fixed. Immune pressure of host organism leads to elimination of non-mutated version of 
antigens and mutated version becomes more frequent. The pN/pS test is more general as it shows 
whether non-synonymous polymorphisms tend to occur in a given gene or sets of genes. It is 
expected that elevated number of non-synonymous mutations manifested as polymorphisms in 
antigens is the adaptation to the pressure of host immune system and does not result only from 
relaxation of selection constraint. 
To investigate different protein classes we divided all expressed proteins according to two 
different criteria. First of them was cellular location and the proteins were classified as 
membrane (containing at least one transmembrane domain or predicted signal peptide) and non-
membrane. Prediction of signal peptides in PlasmoDB is provided by SignalIP program 
(Petersen et al., 2011) and transmembrane domains are predicted by TMHMM2 (Krogh et al., 
2001), for both of them we used the PlasmoDB default settings. We decided to classify proteins 
containing signal peptides as membrane-associated because they have similar properties to those 
containing transmembrane domains (i.e. in both cases proteins can be expressed on the surface of 
the cell). The second classification (into antigenic and non-antigenic) was based on the 
antigenicity of proteins. Proteins are considered as antigenic if they contain experimentally 
evident epitopes (T cells, B cells or MHC binding) provided by IEDB website. In PlasmoDB 
there is an option (‘Epitope Presence’) which allows for identification of proteins containing 
epitopes from IEDB and we took advantage of this tool. 
All necessary calculations and statistical analysis were done in R-project. In order to analyze the 
data we have applied the χ2 test, the bootstrap confidence intervals, Wilcoxon test (known also as 
Mann-Whitney U test) and Kruskal-Wallis test.  
3. Results and Discussion 
3.1. Proteome analysis 
We have found a set of 161 proteins common to all investigated parasite lifecycle stages (which 
is 6.75 % of all proteins). Some other are shared between two or three stages (respectively 560 
and 310 proteins) and the rest 1353 (56.75 %) are proteins unique only to one form (stage-
specific proteins).The results are presented by the Venn diagram in Fig. 1A.  
Additional analysis was performed according to the cellular location of proteins. We have 
distinguished membrane-associated and non-membrane proteins. The same division we did for 
the whole proteome was done for those two groups and presented in the Fig. 1B and 1C. 
Another division important for this research took into consideration the presence of epitopes. The 
PlasmoDB website provides proteins containing experimentally evident epitopes mapped on the 
basis of the results collected in the IEDB database. Fig. 2. presents the percentage distribution of 
antigenic and non-antigenic proteins in the main four developmental stages taking into 
consideration all the proteins expressed in each stage. The plot in the Fig. 3. shows the same 
distribution but considers only proteins unique to the given form. 
From the above plots (Fig 2 and 3) it can be noticed that sporozoites are characterized by the 
highest number of proteins containing epitopes in both the case of membrane-associated and 
non-membrane proteins. However this tendency is stronger if we consider only stage-specific 
proteins. We used the χ2 test to assess the statistical significance of this distribution. The results 
revealed that the type of expressed proteins is strongly dependent on the developmental stage of 
P. falciparum. Significantly higher number of antigenic proteins expressed in sporozoite may be 
explained by the fact that this form of parasite is able to infect both mosquito and human. It 
means that the parasite must be able to attack different target cells and for this purpose more 
specialized proteins may be required. (Garcia et al., 2006).  
3.2. Analysis of diversifying selection 
For this analysis we took into consideration only stage specific proteins i.e. proteins that are 
expressed exclusively in one developmental stage. We started from the estimation of an average 
ratio of the number of non-synonymous single nucleotide polymorphisms (pN) to that of 
synonymous ones (pS) for each developmental stage of P. falciparum. 
We calculated the average pN/pS ratio values for all stage specific proteins expressed in all 
investigated stages and we got the following results: 2.10 (merozoite), 2.26 (trophozoite), 1.92 
(gametocyte) and 2.91 (sporozoite). The results are presented in the Fig. 4. We used Kruskal-
Wallis test to check whether the distribution in all four developmental stages is the same or not. 
We obtained p-value equal to 5.09·10-6, which means that there are statistically important 
differences between these groups. Further investigation by pairwise comparison of all stages 
between each other revealed that sporozoite is significantly different from other stages and that 
there are no significant differences between merozoite, trophozoite and gametocyte To further 
analyze the estimates of pN/pS values, we investigated how they differ across the 4 considered 
stages regarding the distinction of proteins with epitopes. The average values of pN/pS ratio for 
antigenic and non-antigenic proteins in all developmental stages are presented in the Fig. 5. 
Confidence intervals were calculated by bootstrap method with 10000 random permutations of 
the data. We used Wilcoxon rank sum test to evaluate the differences in means between antigenic 
and non-antigenic proteins. The results indicate that in all four stages there is a statistically 
significant difference between pN/pS values for antigenic and non-antigenic proteins. We 
obtained the following p-values: 1.96·10- 6 (merozoite), 7.85·10-5 (trophozoite), 4.85·10-14 
(gametocyte), 6.89·10-8 (sporozoite). These observations are consistent with the theory that in the 
case of antigenic proteins, positive natural selection is expected in order to maintain genetic 
diversity (Escalante et al., 2004). 
In the next step of the research, we divided the same set of proteins into different classes. This 
time we analyzed the membrane-associated and non-membrane proteins in all developmental 
stages (Fig. 6). Again the Wilcoxon test was used to assess whether the difference in means is 
significant. In this case only we obtained significant p-value only for trophozoite (P=9.04·10-3). 
The shape of the plot suggests that the dependencies are similar to those presented by the 
previous plot although not significantly so. The observation that genes coding for membrane-
associated proteins in Plasmodium are characterized by higher pN/pS ratio has been previously 
demonstrated by Volkman et al. (2002). The fact that membrane-associated proteins can be 
antigenic is not surprising. However, some non-membrane proteins are also able to induce an 
immune response for example in case of autoimmune diseases (Dumont, Payseur, 2011 and 
Worman, Courvalin, 2003)We have also noticed that there is a certain problem with searching 
for Plasmodium membrane proteins in PlasmoDB.  The database’s tools allow only for 
identification of proteins containing at least one transmembrane domain and it does not take into 
consideration GPI-anchored proteins, which should also be classified as membrane-associated. 
The research done by Gilson et al. (2006) shows that there exist some proteins that do not 
possess transmembrane domains but are GPI-anchored. This fact can slightly influence the 
values that we obtained in our analysis. Moreover, it may be expected that at least some proteins 
that we have identified as non-membrane antigens are in fact GPI-anchored proteins. For 
example merozoite surface protein 2 (MSP-2) coded by gene PFB0300c (Gilson et al., 2006).  
From each developmental stage taken into account, we selected antigenic membrane-associated 
and non-membrane proteins that are characterized by the highest pN/pS value. The results are 
presented in tables 1 and 2 (full list of pN/pS scores is provided as supplementary material). 
Such proteins contain both experimentally evident epitopes and elevated pN/pS ratio indicated 
that they are antigens which are subject of the strongest diversifying selection in a given stage.  
Table. 1. Membrane-associated proteins with epitopes found to be under strong diversifying 
selection 
Gene ID Stage Product name GO function GO process 
pN/pS 
ratio 
PFD0230c 
Merozoite dipeptidyl peptidase 3   11.0 
PFB0105c Merozoite 
Plasmodium exported protein (PHISTc), 
unknown function 
null null 9.00 
PFL2565w 
Merozoite 
Plasmodium exported protein (PHISTa), 
unknown function, pseudogene 
 
metal ion binding, transferase 
activity 
 
null 7.00 
PF13_0338 
Merozoite 
cysteine-rich surface protein (Pf92) 
 
null 
attachment of GPI anchor to 
protein 
 
7.00 
PFL1330c 
Merozoite 
cyclin (CYC2) 
 
null 
negative regulation of cyclin-
dependent protein kinase 
activity, regulation of cell cycle 
 
6.33 
PFL0050c 
Trophozoite Plasmodium exported protein (PHISTb), 
unknown function 
ATP binding null 15.00 
PFB0675w 
Trophozoite conserved Plasmodium membrane 
protein, unknown function 
null null 15.00 
PFL0035c 
Trophozoite 
acyl-CoA synthetase (ACS7) catalytic activity metabolic process 14.00 
PFA0620c 
Trophozoite 
glutamic acid-rich protein (GARP) null null 9.00 
PF10_0160 
Trophozoite serine/threonine protein kinase, FIKK 
family (FIKK10.1) 
ATP binding, protein 
serine/threonine kinase activity 
protein phosphorylation 9.00 
PFA0340w Gametocyte 
2-C-methyl-D-erythritol 4-phosphate 
cytidylyltransferase, putative 
catalytic activity 
translation, translational 
initiation 
16.00 
PF13_0248 
 
Gametocyte 
6-cysteine protein (P47) null 
attachment of GPI anchor to 
protein 
14.00 
PFB0190c Gametocyte 
conserved Plasmodium protein, unknown 
function 
binding, transferase activity null 10.00 
PF14_0313 
Gametocyte conserved Plasmodium protein, unknown 
function 
ATP binding, DNA binding 
cell cycle, cell division, 
chromosome segregation 
6.00 
PF14_0732 
Gametocyte Plasmodium exported protein (PHISTb), 
unknown function 
nucleotide binding null 
6.00 
PF10_0095 
Gametocyte conserved Plasmodium membrane 
protein, unknown function 
null null 
6.00 
PFE1180c 
Gametocyte conserved Plasmodium membrane 
protein, unknown function 
null null 
6.00 
PF13_0201 Sporozoite sporozoite surface protein 2 null cellular component movement 50.00 
PFL0440c Sporozoite zinc finger protein, putative protein binding, zinc ion binding null 25.00 
PFL0800c Sporozoite 
cell traversal protein for ookinetes and 
sporozoites 
null null 22.00 
PFB0920w Sporozoite DnaJ protein, putative 
heat shock protein binding, 
unfolded protein binding 
protein folding 14.00 
PF14_0736 
 
Sporozoite 
Plasmodium exported protein, unknown 
function  
ATP binding, ATPase activity, 
coupled to transmembrane 
movement of ions, 
phosphorylative mechanism 
ATP biosynthetic process 
14.00 
Table. 2. Non-membrane proteins with epitopes found to be under strong diversifying selection 
Gene ID Stage Product name GO function GO process 
pN/pS 
ratio 
PFD0180c Merozoite CGI-201 protein, short form RNA binding 
RNA processing, spliceosome 
assembly 
24.00 
PFB0300c Merozoite merozoite surface protein 2 null 
attachment of GPI anchor to 
protein, cell adhesion 
19.00 
PF14_0379 
Merozoite conserved Plasmodium protein, 
unknown function 
ATP binding, actin binding, motor 
activity 
null 
16.00 
PF11_0362 
Merozoite 
protein phosphatase, putative catalytic activity null 
10.00 
PF14_0537 Merozoite 
conserved Plasmodium protein, 
unknown function 
ATP binding, arginine-tRNA ligase 
activity, glycine-tRNA ligase 
activity 
arginyl-tRNA aminoacylation, 
glycyl-tRNA aminoacylation, 
translation 
8.00 
PF14_0374 Trophozoite 
CCAAT-binding transcription factor, 
putative 
sequence-specific DNA binding null 14.00 
PFE1320w Trophozoite 
conserved Plasmodium protein, 
unknown function 
binding 
RNA splicing, cell cycle, mRNA 
processing 
13.50 
PFL2010c 
Trophozoite DEAD/DEAH box ATP-dependent 
RNA helicase, putative 
ATP binding, ATP-dependent 
RNA helicase activity, nucleic acid 
binding 
RNA metabolic process 
13.00 
PF10_0278 
Trophozoite nucleolar preribosomal assembly 
protein, putative 
null null 
11.00 
PFF0480w Trophozoite 
conserved Plasmodium protein, 
unknown function 
null null 9.67 
PF07_0069 Gametocyte 
conserved Plasmodium protein, 
unknown function 
null null 16.00 
PFE0780w Gametocyte 
conserved Plasmodium protein, 
unknown function 
null phosphate transport 13.00 
MAL13P1.260 Gametocyte alveolin, putative transferase activity null 12.00 
PF10_0078 Gametocyte histone deacetylase, putative 
inositol trisphosphate 3-kinase 
activity 
null 11.50 
PFF1065c Gametocyte 
conserved Plasmodium protein, 
unknown function 
null null 11.00 
PF14_0135 Gametocyte 
conserved Plasmodium protein, 
unknown function 
null null 11.00 
PF14_0727 
 
Sporozoite conserved Plasmodium protein, 
unknown function 
null null 
46.00 
PF14_0073 Sporozoite 
conserved Plasmodium protein, 
unknown function 
ATP binding, protein binding null 18.00 
PFL1565c 
Sporozoite CG2-related protein, putative null null 17.00 
MAL7P1.76 
Sporozoite conserved Plasmodium protein, 
unknown function 
null null 
17.00 
PF13_0120 Sporozoite 
conserved Plasmodium protein, 
unknown function 
ATP binding, actin binding, 
calmodulin binding, motor activity 
null 15.00 
MAL13P1.296 Sporozoite 
conserved Plasmodium protein, 
unknown function 
hydrolase activity null 15.00 
 
4. Conclusions 
Our aim was to analyze immune pressure acting on different stages of malaria life cycle. We 
identified proteins which are under putative immune pressure taking into consideration two 
criteria: presence of epitopes from the IEDB and pN/pS ratio, which is an approximate measure 
of host immune pressure. We confirmed the expectations that proteins which contain epitopes 
have elevated pN/pS ratio. This observation suggests that it is likely that both methods detect the  
pressure of host immune system. Using this approach we asked the question, what was the 
ecology of interactions between host immune system and parasite. Comparison of plots showing 
pN/pS ratios for different protein classes (Fig. 5. and 6.) confirmed that antigenicity has stronger 
impact on diversifying selection than cellular location. This observation confirms that hypothesis 
that elevated pN/pS ratio of membrane proteins is a result of immune pressure (Volkman 2002) 
is true. The same analysis repeated with Ka/Ks ratio test gave mostly the same dependencies 
which suggests that both the method and the results are correct.  
As  examples of proteins which could be interesting for further investigation, we have identified 
five to seven proteins from each developmental stage with the highest pN/pS values. Membrane-
associated and non-membrane proteins were distinguished for each stage. The data are presented 
in the tables 1 and 2. 
The results obtained also indicate that among all investigated developmental stages, that of the 
sporozoite contains the highest fraction of antigenic proteins (42.77 % for all proteins and 
41.83 % for stage-specific ones). This form is also under particularly strong immune pressure 
which is indicated by the highest pN/pS values. Since the proteins expressed in this stage - 
currently believed to be non-antigenic - are characterized by higher pN/pS value than those from 
other stages, we suspect that a high number of sporozoite-specific epitopes remains 
undiscovered. 
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Figures captions 
Fig. 1. Distribution of Plasmodium falciparum proteins across four developmental stages. A. 
All proteins. B. Non-membrane proteins. C. Membrane-associated proteins. Numbers represent 
the amount of genes expressed in the particular life stages. Data were obtained from PlasmoDB 
website (Florens et al., 2002). 
Fig. 2. Distribution of all proteins in four main stages, categorized into different groups: 
non-membrane without epitopes, non-membrane with epitopes,  membrane without 
epitopes and membrane with epitopes. 
Numbers in the boxes represent the amount of protein coding genes expressed in the particular 
life stages. Different classes of proteins encoded by the respective genes are marked with 
different colors. Data were obtained from PlasmoDB website (Florens et al., 2002). 
Fig. 3. Distribution of stage-specific proteins in four main stages, categorized into different 
groups: non-membrane without epitopes, non-membrane with epitopes,  membrane 
without epitopes and membrane with epitopes. 
Numbers in the boxes represent the amount of protein coding genes expressed in the particular 
life stages. Different classes of proteins encoded by the respective genes are marked with 
different colors. Data were obtained from PlasmoDB website (Florens et al., 2002). 
Fig. 4. Estimates of pN/pS of stage- specific proteins across the four main P. falciparum 
stages. 
Mean values and 95 % confidence intervals of the pN/pS ratio were calculated for each 
developmental stage.  
Fig. 5. Comparison between estimates of pN/pS across all considered forms with divisions 
into antigenic and non-antigenic protein classes.  
Fig. 6. Comparison between estimates of pN/pS across all considered forms with divisions 
into non-membrane and non-membrane protein classes. 
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